Stay updated on Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Compared with the prior screenshot, there are no changes to core study information (title, eligibility criteria, outcomes, enrollment); observed differences appear to be minor UI/layout refinements. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:05:49.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Location region renamed (Rhône-Alpes -> Auvergne-Rhône-Alpes) and revision updated to v3.2.0; Lyon address adjusted to the new region.
    Difference
    5%
    Check dated 2025-10-06T05:19:21.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.0%
    Check dated 2025-09-29T03:01:10.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed as a minor UI change; overall, the substantive update is the version bump.
    Difference
    0.1%
    Check dated 2025-09-14T18:55:19.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T14:08:21.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous location details across various countries and regions, while also removing outdated location references and related topics. Notably, the facility name and specific locations have been clarified and expanded.
    Difference
    17%
    Check dated 2025-08-31T11:38:58.000Z thumbnail image

Stay in the know with updates to Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page.